Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elwira Przybylik-Mazurek is active.

Publication


Featured researches published by Elwira Przybylik-Mazurek.


Biological Trace Element Research | 2011

Thyroid Disorders—Assessments of Trace Elements, Clinical, and Laboratory Parameters

Elwira Przybylik-Mazurek; Paweł Zagrodzki; Sylwia Kuźniarz-Rymarz; Alicja Hubalewska-Dydejczyk

The trace elements studied in this work (Se, Cu, Zn) are the essential constituents or cofactors required to activate numerous enzymes and proteins, playing crucial role in various physiological processes. The disturbed levels of abovementioned elements may adversely affect the endocrine system, resulting in various thyroid disorders among other upsets. The aim of this study was to investigate possible associations between them and parameters of redox balance, thyroid function indices as well as clinical records (duration of disease and therapy, lag time between thyroid surgery and this study examination, LT4 dosage) in patients with different thyroid disorders, including malignant diseases of the gland. In the group of patients with papillary carcinoma, we found a statistically significant higher Cu concentration compared with controls and patients with Hashimoto disease. In the same groups, the parameter of Zn/Cu ratio demonstrated reciprocally arranged statistically significant differences. For the group of papillary cancer patients, there was a negative correlation between lag time since thyroid operation and GPX3 activity. Our data support hypothesis of indirect involvement of Zn and Cu in thyroid regulation. For selenium, lack of simple correlation between its serum level and thyroid indices implies the need for further research on other selenium status parameters more adequately depicting changes in endocrine system.


Journal of Endocrinological Investigation | 2008

Effectiveness of the iodine prophylaxis model adopted in Poland

Szybiński Z; Filip Gołkowski; Monika Buziak-Bereza; Malgorzata Trofimiuk; Elwira Przybylik-Mazurek; Huszno B; Elżbieta Bandurska-Stankiewicz; E. Bar-Andziak; B. Dorant; Kinalska I; Lewinski A; M. Klencki; Rybakowa M; Jerzy Sowiński; Szewczyk L; L. Szponar; Wasik R

Objective: Most of the Polish territory has been classified as an iodine-deficient and endemic goiter area according to the International Council for Control of Iodine Deficiency (ICCIDD) criteria. In 1997 the obligatory model of iodine prophylaxis was implemented. Our investigations were aimed at the effectiveness of iodine prophylaxis in Poland. Methods: We assessed urinary iodine excretion and goiter prevalence in 5663 children aged 6–12 yr. The population of children from the same 27 schools was investigated from 1992 to 1994 (1406 girls and 1244 boys) and from 1999 to 2005 (1563 girls and 1450 boys) using identical laboratory and ultrasound methods. Results: We found significant increase in iodine urinary concentration (median 52 μg/l vs 93 ug/l, p<0.001) with accompanying drop in goiter prevalence (29.6% vs 5.2%, p<0.001) after implementation of iodine prophylaxis. Iodine excretion distribution changed significantly after 1997 with an increase in the percentage of children with iodine urinary concentration above 100 μg/l from 10.8% to 45.4%, respectively. A significantly higher iodine urinary concentration was observed in lowlands compared to uplands both before and after implementation of iodine prophylaxis (median, 50 νg/l vs 57 μg/l and 86 μg/l vs 114 μg/l, respectively, p<0.001). The goiter prevalence did not differ between girls and boys from 1992 to 1994 (28.8% vs 30.5%, p=0.35) and 1999 to 2005 (5.5% vs 4.9%, p=0.45). Conclusions: Implementation of the new model of iodine prophylaxis in Poland in 1997 has led to significant increase in iodine urinary concentration and decrease in goiter prevalence among Polish schoolchildren. In the youngest group of children (6–8 yr olds), prevalence of goiter decreased to 3.2% — i.e. below endemic levels.


Nuclear Medicine Review | 2011

Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?

Anna Sowa-Staszczak; Dorota Pach; Agnieszka Stefanska; Monika Tomaszuk; Wioletta Lenda-Tracz; Renata Mikolajczak; Dariusz Pawlak; Robert Chrzan; Aleksandra Gilis-Januszewska; Elwira Przybylik-Mazurek; Alicja Hubalewska-Dydejczyk

BACKGROUND The aim of the study was to assess the effectiveness of peptide receptor radionuclide therapy (PRRT) in patients with non-functioning neuroendocrine pancreatic tumours (NFPNTs) and to compare survival rates in patients with NFPNTs and in patients with other neuroendocrine tumours (NETs) treated using radiolabelled somatostatin analogue in our Department. We would like to analyze factors potentially determining the effectiveness of the therapy and also to assess the myelo- and nephrotoxicity. MATERIAL AND METHODS Fourteen patients with disseminated disease and/or inoperable NFPNT were qualified to PRRT based on positive SRS (somatostatin receptor scintigraphy). There were 5 men and 9 women, with Karnofskys index>70%. RESULTS In the whole group of patients, partial response was observed in 21.4%, stabilization of the disease in 42.9%, and progression of the disease in 35.7% of patients. Mean observation time was 19±13 months, mean time to progression was 12±9 months, and mean time to death was 16±9 months. Six patients died--four of them due to progression of the disease, two due to myocardial infarction. After PRRT we did not observe clinically significant haemotoxicity and/or nephrotoxicity. CONCLUSIONS 1. Peptide receptor radionuclide therapy may be a safe and effective treatment option in patients with NFPNTs, leading to stabilization or regression of the disease in the majority of patients. 2. There is no statistically significant difference in survival rate between patients with NFPNTs and NETs of other localization treated with PRRT.


Postepy Higieny I Medycyny Doswiadczalnej | 2012

Dietary patterns as risk factors of differentiated thyroid carcinoma.

Elwira Przybylik-Mazurek; Alicja Hubalewska-Dydejczyk; Sylwia Kuźniarz-Rymarz; Malgorzata Kiec-Klimczak; Anna Skalniak; Anna Sowa-Staszczak; Filip Gołkowski; Marta Kostecka-Matyja; Dorota Pach

UNLABELLED Nutritional factors are known to be important in the development of different metabolic diseases. The history of nodular or diffuse goiter is closely related to risk of thyroid carcinoma. On account of the function of the thyroid gland, many studies focus on iodine intake. The aim of the study was to assess whether dietary patterns could be risk factors of differentiated thyroid carcinoma. MATERIAL/METHODS The case-control study was based on a questionnaire, which included information about dietary patterns and was carried out on 284 patients comprising 30 males (mean age 58.4±13.7 years), and 254 females (mean age 52.1±13.8 years), as well as 345 randomly selected controls: 58 males (mean age 60.2±12 years) and 287 females (mean age 53.4±14.3 years) randomly selected from the Population Register and adjusted by age and gender to the group of TC. The main groups of nutritional products, i.e. starchy foods, meat, dairy products, vegetables, fruits, and beverages, were analyzed. RESULTS Consumption of vegetables, fruits, saltwater fish and cottage cheese was significantly lower in patients with differentiated thyroid carcinoma than in controls, quite the contrary to starchy foods, especially white bread. CONCLUSIONS Dietary patterns appear to modify the risk of thyroid carcinoma. A diet rich in vegetables and fruit, as well as saltwater fish (a source of iodine) and low-fat meat, could be an important protective factor.


Endocrine Research | 2010

Selenium and Hormone Interactions in Female Patients with Hashimoto Disease and Healthy Subjects

Paweł Zagrodzki; Elwira Przybylik-Mazurek

Objective. To examine the correlation structure of parameters expressing selenium status, sex hormones secretion and thyroid function in a group of patients with Hashimoto disease and healthy female subjects. Method. Partial Least Square modeling was applied to parameters under study. Results. The correlations between relevant parameters were confirmed. Selenoenzyme glutathione peroxidase (GPX3) an progesterone played the most significant roles among factors contributing to thyroid stimulating hormone and free thyroxine regulation. Additionally, a correlation between GPX3 and estradiol was also observed which is in agreement with results reported by other authors. Patients with Hashimoto disease had lower glutathione peroxidase activities than healthy subjects. Conclusion. The integrated multivariate approach applied to a new group of patients dissimilar to the previous one, was validated by statistical adequacy as well ass meaningful interpretation.


European Journal of Endocrinology | 2001

A programme of iodine supplementation using only iodised household salt is efficient - the case of Poland

Szybiński Z; Delange F; Lewinski A; Podoba J; Rybakowa M; Wasik R; Szewczyk L; Huszno B; Filip Gołkowski; Elwira Przybylik-Mazurek; Karbownik M; Zak T; Pantoflinski J; Malgorzata Trofimiuk; Kinalska I


Journal of Endocrinological Investigation | 2003

Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland.

Szybiński Z; Huszno B; B. Zemla; Elżbieta Bandurska-Stankiewicz; Elwira Przybylik-Mazurek; W. Nowak; S. Cichon; Monika Buziak-Bereza; Malgorzata Trofimiuk; P. Szybinski


Journal of Endocrinological Investigation | 2003

Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area.

Huszno B; Szybiński Z; Elwira Przybylik-Mazurek; J. Stachura; Malgorzata Trofimiuk; Monika Buziak-Bereza; Filip Gołkowski; J. Pantoflinski


European Journal of Nutrition | 2007

Iodine prophylaxis—the protective factor against stomach cancer in iodine deficient areas

Filip Gołkowski; Szybiński Z; Jadwiga Rachtan; Andrzej Sokołowski; Monika Buziak-Bereza; Malgorzata Trofimiuk; Alicja Hubalewska-Dydejczyk; Elwira Przybylik-Mazurek; Huszno B


Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine | 2003

Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome. Report of four cases

Zbigniew Rudzki; Anna Matynia; Elwira Przybylik-Mazurek; Andrzej Darczuk; Szybiński Z; Beata Piatkowska-Jakubas; Malgorzata Wojcik; Aleksander B. Skotnicki

Collaboration


Dive into the Elwira Przybylik-Mazurek's collaboration.

Top Co-Authors

Avatar

Alicja Hubalewska-Dydejczyk

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Dorota Pach

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Huszno B

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Anna Skalniak

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Aleksandra Gilis-Januszewska

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Szybiński Z

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge